Nuage Therapeutics
Develops new selective and potent drugs for intrinsically disordered targets.
Launch date
Employees
Market cap
-
Enterprise valuation
$53—79m (Dealroom.co estimates Jun 2023.)
Company register number B16765380
Barcelona Catalonia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
N/A | Seed | ||
* | €450k | Seed | |
* | €12.0m | Early VC | |
| Total Funding | $13.7m | ||